Back to Search

GARY SUTTER, MD

MD

Internal Medicine Physician

NPI: 1821150459Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

G35914(CA)

Research & Publications (20)

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
PMID 15958679·J Gen Virol·2005
7-preclinical
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.
PMID 19211768·J Virol·2009
7-preclinical
Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.
PMID 19129447·J Virol·2009
7-preclinical
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
PMID 19012492·J Infect Dis·2009
7-preclinical
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.
PMID 19348560·Expert Rev Vaccines·2009
6-review
Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
PMID 19073732·J Virol·2009
7-preclinical
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
PMID 19061423·J Infect Dis·2009
7-preclinical
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
PMID 19038289·J Virol Methods·2009
7-preclinical
The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
PMID 19357172·J Virol·2009
7-preclinical
Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
PMID 18291561·Vaccine·2008
7-preclinical
The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex.
PMID 18353424·Virology·2008
7-preclinical
In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences.
PMID 18774154·Virology·2008
7-preclinical
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
PMID 18952300·Vet Immunol Immunopathol·2008
4-observational
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
PMID 18076128·J Gene Med·2008
7-preclinical
Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization.
PMID 18816482·J Gene Med·2008
7-preclinical
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
PMID 17471429·J Infect Dis·2007
7-preclinical
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
PMID 17499893·Vaccine·2007
4-observational
Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
PMID 17604541·AIDS Res Hum Retroviruses·2007
3-trial
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.
PMID 17699574·J Virol·2007
7-preclinical
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
PMID 17855554·J Virol·2007
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1025 W OLYMPIC BLVD
LOS ANGELES, CA 90015

Location

Practice Location

1025 W OLYMPIC BLVD, LOS ANGELES, CA
(213) 236-0311

Quick Facts

NPI
1821150459
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile